NEW DELHI, Nov. 29 (Xinhua) -- The Serum Institute of India (SII) on Sunday rejected the allegation levelled by a COVID-19 vaccine volunteer who sued the company for 5 crore Indian Rupees (around 675,675 U.S. dollars) for having developed side effects.
The Institute described the allegations as "malicious and misconceived".
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!